Your browser doesn't support javascript.
loading
Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents.
Geisler, Caroline E; Antonellis, Meghan P; Trumbauer, Wolfgang; Martin, Jennifer A; Coskun, Tamer; Samms, Ricardo J; Hayes, Matthew R.
  • Geisler CE; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Antonellis MP; Diabetes, Obesity and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
  • Trumbauer W; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Martin JA; Diabetes, Obesity and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
  • Coskun T; Diabetes, Obesity and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
  • Samms RJ; Diabetes, Obesity and Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
  • Hayes MR; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Diabetes Obes Metab ; 25(1): 56-67, 2023 01.
Article en En | MEDLINE | ID: mdl-36054312

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Roedores / Pérdida de Peso Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Roedores / Pérdida de Peso Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article